Oxadiazolone‐Triazole Derivatives as a New Scaffold for Modulation of Angiotensin II‐Induced Vascular Contraction
Larissa F L Ferreira, Daiana G de A Vasconcelos, Ruth C A Santos, Jivaldo G Ferreira, Alice V Araújo, Janaína V dos Anjos · 2026
Read Oxadiazolone‐Triazole Derivatives as a New Scaffold for Modulation of Angiotensin II‐Induced Vascular Contraction by Larissa F L Ferreira, Daiana G de A Vasconcelos, Ruth C A Santos, Jivaldo G Ferreira, Alice V Araújo, Janaína V dos Anjos (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13530322.txt.
Description
Larissa Ferreira and five colleagues published a drug design study in two thousand twenty-six on new blood pressure drug candidates. Blocking the angiotensin receptor lowers blood pressure and eases strain on vessels. The team built a fresh family of blockers joining two ring structures.
Ten compounds were made through a click chemistry route in fair to good yields. In rat artery rings, most blunted the squeeze caused by angiotensin. One compound, labelled 7f, performed best in the set. Groups that donate electrons helped activity, while a strong withdrawing group hurt it. Computer docking placed the molecules neatly on the receptor. Predicted body handling looked drug-like, with no entry into the brain expected.
Catalog record
| CREATOR | Larissa F L Ferreira, Daiana G de A Vasconcelos, Ruth C A Santos, Jivaldo G Ferreira, Alice V Araújo, Janaína V dos Anjos |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 46 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |